Less Ads, More Data, More Tools Register for FREE

Pin to quick picksTILS.L Regulatory News (TILS)

  • There is currently no data for TILS

Share Finance Facility

15 Sep 2005 08:00

ReGen Therapeutics PLC15 September 2005 ReGen Therapeutics Plc Date 15 September 2005 Committed Share Finance Facility ReGen Therapeutics Plc ("ReGen" or the "Company") announces that on 14thSeptember 2005 it entered into an agreement with the Headstart Group of funds ("Headstart") under which Headstart will make available to the Company acommitted share finance facility of up to £2,000,000 (the "Headstart Facility"). Pursuant to the terms of the Headstart Facility, Headstart has agreed, whencalled upon by the Company, to subscribe for, or purchase, new ordinary sharesin the capital of the Company ("Ordinary Shares") to the value of up to, inaggregate, £2,000,000. The Headstart Facility is available at any time up to 3years from the date a Committed Share Finance Facility Agreement is entered intoby the Company and Headstart and can be drawn down by the Company in incrementsof up to £50,000. The subscription price for an Ordinary Share shall be equalto 95% of the lowest closing bid price of an Ordinary Share in the fifteentrading days following the date on which the Company notifies Headstart that itwishes to make a draw down under the Headstart Facility. In consideration for Headstart making available the Headstart Facility, theCompany has agreed to pay Headstart a one-off underwriting commission of £60,000payable by the issue of Ordinary Shares (on the basis of an agreed value perOrdinary Share of 1.35p, being the closing bid price on Wednesday 7th September2005). £30,000 of the underwriting commission was payable upon entering into theHeadstart Facility and the remaining £30,000 is payable on the first anniversarythereafter. Accordingly, application has been made for 2,222,222 OrdinaryShares to be admitted to trading on the AIM market. It is expected thatadmission to listing will become effective and that dealings in these shareswill commence on Tuesday 20th September 2005. In addition, the Company hasagreed, subject to shareholder approval, to issue warrants granting Headstartthe right to subscribe for up to 4,000,000 Ordinary Shares at a subscriptionprice of 1.65p per share, being a price equal to 110% of the closing bid priceof the Company's shares on 13th September 2005. Such warrants will beexercisable at any time on or before 14th September 2008. As the issue of theWarrants is subject to shareholder approval, ReGen will shortly send toshareholders a circular containing a notice convening an extraordinary generalmeeting of the Company (the "Circular") for 10.00 a.m. on 10 October 2005 (the "EGM") containing resolutions to, inter alia, approve the issue of the Warrants. Copies of the Circular will be available, for collection only, free of charge tothe public, from the Company, Suite 406, Langham House, 29-30 Margaret Street,London W1W 8SA during normal office hours on any day (Saturdays, Sundaysexcepted) from 19 September 2005 until 14 October 2005. - For further information, please contact:Andrew MarshallMarshall Robinson RoeTel No 020 7960 6007 This information is provided by RNS The company news service from the London Stock Exchange
Date   Source Headline
29th Jun 202011:00 amRNSPrice Monitoring Extension
29th Jun 20209:05 amRNSSecond Price Monitoring Extn
29th Jun 20209:00 amRNSPrice Monitoring Extension
29th Jun 20207:00 amRNSAgreement with STC Biologics
23rd Jun 202012:20 pmRNSNotice of AGM
22nd Jun 20207:00 amRNSExercise of Warrants and Issue of Equity
19th Jun 20209:05 amRNSSecond Price Monitoring Extn
19th Jun 20209:00 amRNSPrice Monitoring Extension
19th Jun 20207:00 amRNSPatent Granted for Oral Administration
18th Jun 20205:30 pmRNSDirectorate Change
18th Jun 20207:00 amRNSFinal Results
12th Jun 20207:00 amRNSExtension of At the Market Sales Agreement
4th Jun 20207:00 amRNSAnti-CD3 for Alzheimer Disease
2nd Jun 20204:03 pmRNSCorrection Issue of Equity and Total Voting Rights
2nd Jun 20207:00 amRNSIssue of Equity and Total Voting Rights
1st Jun 20207:00 amRNSChange of Adviser
29th May 20207:00 amRNSFurther re: ASCO Conference - StemPrintER
26th May 20204:42 pmRNSSecond Price Monitoring Extn
26th May 20204:37 pmRNSPrice Monitoring Extension
22nd May 20209:05 amRNSSecond Price Monitoring Extn
22nd May 20209:00 amRNSPrice Monitoring Extension
22nd May 20207:00 amRNSIntention to Demerge StemPrintER
21st May 20204:05 pmRNSHolding(s) in Company
18th May 20202:39 pmRNSExercise of Warrants and Issue of Equity
18th May 202011:05 amRNSSecond Price Monitoring Extn
18th May 202011:00 amRNSPrice Monitoring Extension
14th May 20203:00 pmRNSASCO Conference - Milciclib
14th May 20202:06 pmRNSSecond Price Monitoring Extn
14th May 20202:00 pmRNSPrice Monitoring Extension
14th May 202011:05 amRNSSecond Price Monitoring Extn
14th May 202011:00 amRNSPrice Monitoring Extension
14th May 20209:05 amRNSSecond Price Monitoring Extn
14th May 20209:00 amRNSPrice Monitoring Extension
14th May 20207:00 amRNSASCO Conference - StemPrintER
13th May 202011:06 amRNSSecond Price Monitoring Extn
13th May 202011:00 amRNSPrice Monitoring Extension
11th May 202010:47 amRNSHolding(s) in Company
11th May 20207:00 amRNSASCO Conference
7th May 202011:06 amRNSSecond Price Monitoring Extn
7th May 202011:00 amRNSPrice Monitoring Extension
6th May 202012:13 pmRNSResult of GM
6th May 20207:00 amRNSHolding(s) in Company
1st May 20207:00 amRNSTotal Voting Rights
28th Apr 20202:00 pmRNSPrice Monitoring Extension
28th Apr 202011:05 amRNSSecond Price Monitoring Extn
28th Apr 202011:00 amRNSPrice Monitoring Extension
27th Apr 20202:01 pmRNSPrice Monitoring Extension
27th Apr 20201:30 pmRNSPatent Application Filing
24th Apr 20206:29 pmRNSAcquisition of Technology
24th Apr 20207:00 amRNSIssue of Equity and Update on AIM Cancellation

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.